References
- Astrup T., Müllertz S. The fibrin plate method for estimating fibrinolytic activity. Arch Biochem 1952; 40: 346
- Bailar J. C. Thromboembolism and oestrogen therapy. Lancet 1967; 2: 560
- Brakman P. Fibrinolysis. A Standardized Fibrin Plate Method and a Fibrinolytic Assay of Plasminogen. Scheltema & Holkema, Amsterdam 1967; 73
- Daniel D. G., Campbell H., Turnbull A. C. Puerperal thromboembolism and suppression of lactation. Lancet 1967; 2: 287
- Dixon W. J., Massey F. J. Introduction to Statistical Analysis. McGraw-Hill, New York 1957; 290
- Fagerhol M. K., Abildgaard U. Immunological studies on human antithrombin III. Influence of age, sex and use of oral contraceptives on serum concentration. Scand J Haemat 1970; 7: 10
- Fagerhol M. K., Abildgaard U., Bergsjo P., Jacobsen J. H. Oral contraceptives and low antithrombin III concentration. Lancet 1974; I: 605
- Furuhjelm M. Läkartidningen 1974; 71: 605
- Ganrot P. O. Determination of α2-macroglobulin as trypsin-protein esterase. Clin Chim Acta 1966; 14: 493
- Howie P. W., Mallinson A. C., Prentice C. R. M., Home C. H. W., McNicol G. P. Effect of combined oestrogen-progestagen oral contraceptives, oestrogen and progestagen on antiplasmin and antithrombin activity. Lancet 1970; 2: 1329
- Ingelman-Sundberg A. Läkartidningen 1976; 73: 202
- Inman W. H. W., Vessey M. P., Westerholm B., Engelund A. Thromboembolic disease and the steroidal content of oral contraceptives. A report to the committee on safety of drugs. Br Med J 1970; 2: 203
- Isacson S. Low fibrinolytic activity of blood and vein walls in venous thrombosis. Scand J Haemat 1971, Suppl. 16
- Jeffcoate T. N. A., Miller J., Roos R. F., Tindall V. R. Puerperal thromboembolism in relation to the inhibition of lactation by oestrogen therapy. Br Med J 1968; 4: 19
- Kullander S., Svanberg L. On climacteric symptoms and their treatment with a new non-steroidal oestrogen. Int J Gynaecol Obstet 1975; 13: 277
- Laurell C. B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Analyt Biochem 1966; 15: 45
- Nilsson I. M., Blombäck B., von Francken I. On an inherited autosomal haemorrhagic diathesis with antihemophilic globulin (AHG) deficiency and prolonged bleeding time. Acta Med Scand 1957; 159: 35
- Oliver M. F. Thrombosis and oestrogens. Lancet 1967; 2: 510
- Owren P. A., Aas K. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand J Clin Lab Invest 1951; 3: 201
- Pandolfi M. Histochemistry and assay of plasminogen activator (s). Rev Eur Etud Clin Biol 1972; 3: 254
- Paraskevas M., Nilsson I. M., Martinsson G. A method for determining serum inhibitors of plasminogen activation. Scand J Clin Lab Invest 1962; 14: 138
- Phillips L. L., Turksor R. N., Southam A. L. Influence of Ovarian function on the fibrinolytic enzyme system. II. Influence of exogenous steroids. Am J Obstet Gynecol 1961; 82: 1216
- Todd A. S. The histological localisation of fibrinolysin activator. J Pathol Bacteriol 1959; 178: 281
- Åstedt B. Low fibrinolytic activity of veins during treatment with ethinyloestradiol. Acta Obstet Gynecol Scand 1971; 50: 279
- Åstedt B., Jeppsson S. 17 β-oestradiol and the fibrinolytic activity of vein walls. J Obstet Gynecol 1974; 81: 719
- Åstedt B., Isacsson S., Nilsson I. M., Pandolfi M. Thrombosis and oral contraceptives: possible predisposition. Br Med J 1973; 4: 631